As technology advances, the practical use of secondary RWD has grown exponentially and is now fueling a new wave of digital disruption.

Advances in technology, from the massive storage and computing options now available through cloud computing to advances in algorithmic processing, have empowered organizations to consider secondary Real-World Data (RWD) sources as viable options for evidence generation across a wide spectrum of use cases. Within the last few years, the exploration and practical use of secondary data has grown exponentially and is now fueling a new wave of digital disruption.

New insights never thought possible are now becoming achievable. The challenge presented with this new era of data use sees unprepared organizations spending massive amounts of resources on secondary data for specific one-off use cases, without thought to how those data may be harmonised across the organization, resulting in large-scale data silos throughout the enterprise. Data silos bring an inherent inefficiency and create roadblocks to achieving the desired success.

In this free webinar, learn about the most common barriers to harmonised RWD and ways to overcome them. Attendees will get insights on:

  • How duplicate data environments, redundant data subscriptions and siloed data access can hinder ROI for real-world evidence generation
  • Practical solutions for developing a collaborative data strategy
  • The benefits of using one centralised data technology platform for RWD

Register Today

To register for this free webinar, visit our webinar partner, xTalks, and complete a one time only form.

Register

Presenters

Bill Row, MBA, MS

Divisional Principal, Real World Evidence Strategy & Analytics, ICON Commercialisation & Outcomes (ICO), ICON plc

Bill Row is a seasoned drug development professional with over 19 years’ experience in study design and execution, portfolio management, department building, strategic planning, and relationship management.  Bill is a recognized leader in the design, operational strategy, commercial, and technology applications of RWE at both pharma and CROs. He has held leadership roles in executive management, clinical operations, project management, and strategy and innovation, with an emphasis on late phase and real world evidence programs. 

Bruce Capobianco

Senior Director, Technology, Real World Evidence Strategy & Analytics, ICON Commercialisation & Outcomes (ICO), ICON plc

Bruce Capobianco has over 25 years’ experience in the architecture, development and implementation of complex big data solutions. He leads a team to develop, enhance, and maintain RWE technology solutions for ICON clients. He has a proven track record of identifying and implementing secure, usable and enduring technologies that augment business processes and optimize productivity. At Syneos he led a global team of architects, developers, PMs and SQA staff in the development of a HIPAA-compliant, trial patient recruitment system, and established and drove disruptive technology trends for competitive advantage. 

Dr. Anand Dubey, PhD

Senior Manager, Ecosystem Innovation, Real World Evidence, Business Solutioning, Saama Technologies

Anand Dubey joined Saama Technologies in April 2017 as Business Solutions Architect, Real World Evidence and is responsible for RWE product and solution development for clinical operational group. Prior to joining Saama, Anand worked at Genpact, a global professional services firm, where he focused on technology-enabled solutions for clinical, data sciences, and commercial team.